# Mapping the Somatic Mutation Landscape of Familial NF2-Related Schwannomatosis using Whole-Exome Sequencing

**Authors:** Fushu Luo, Liangqi Jiang, Yimin Pan, Haoyu Li, Jun Tan, Changwu Wu, Qing Liu

PMC · DOI: 10.7150/ijms.121550 · 2025-10-27

## TL;DR

This study uses whole-exome sequencing to identify somatic mutations in familial NF2-related schwannomatosis, revealing potential genetic contributors to the disease.

## Contribution

The study provides new insights into the somatic mutation landscape of familial NF2-related schwannomatosis using whole-exome sequencing.

## Key findings

- Frequent somatic mutations were identified in genes such as TTN, FLG, CR2, and FSIP2.
- Missense mutations and C>T transitions were the most common types of genetic alterations observed.

## Abstract

Background: Neurofibromatosis type 2 (NF2), currently more accurately named NF2-related schwannomatosis (NF2-SWN), is classified as a multiple tumor syndrome, caused by impaired expression of the merlin protein. Approximately 50% of affected individuals inherit a germline mutation from their parents, while reports on the somatic mutation landscape of other genes are infrequent.

Aim: To further explore the somatic mutations of NF2-SWN and provide a theoretical basis for the treatment of NF2-SWN.

Design: A retrospective study was conducted to follow up on NF2-SWN patients who underwent surgical treatment in the Department of Neurosurgery of Xiangya Hospital. Whole-exome sequencing (WES) was performed on patients with a clear family history.

Methods: This study compiled clinical data from 29 patients diagnosed with NF2-SWN, conducted WES on 7 patients with well-documented genetic histories, and subsequently analyzed their genetic mutations.

Results: Whole-exome sequencing identified frequent somatic mutations in genes such as TTN, FLG, CR2, and FSIP2. Missense mutations and C>T transitions were the most common alteration types.

Conclusion: TTN, CR2, FLG, and FSIP2 demonstrated elevated mutation frequencies in these familial NF2-SWN patients, indicating that these mutations may contribute to the development and progression of familial NF2-SWN.

## Linked entities

- **Genes:** NF2 (NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor) [NCBI Gene 4771], TTN (titin) [NCBI Gene 7273], FLG (filaggrin) [NCBI Gene 2312], CR2 (complement C3d receptor 2) [NCBI Gene 1380], FSIP2 (fibrous sheath interacting protein 2) [NCBI Gene 401024]
- **Proteins:** Nf2 (neurofibromin 2)
- **Diseases:** Neurofibromatosis type 2 (MONDO:0007039), NF2-related schwannomatosis (MONDO:0007039)

## Full-text entities

- **Genes:** TTN (titin) [NCBI Gene 7273] {aka CMD1G, CMH9, CMPD4, CMYO5, CMYP5, EOMFC}, FSIP2 (fibrous sheath interacting protein 2) [NCBI Gene 401024] {aka SPGF34}, NF2 (NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor) [NCBI Gene 4771] {aka ACN, BANF, SCH, SWNV, merlin-1}, FLG (filaggrin) [NCBI Gene 2312] {aka ATOD2, FLG-1, FLG1}
- **Diseases:** Schwannomatosis (MESH:C536641), multiple tumor syndrome (MESH:D009369)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12595425/full.md

---
Source: https://tomesphere.com/paper/PMC12595425